GAMMA Investing LLC decreased its position in Avantor, Inc. (NYSE:AVTR – Free Report) by 37.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,691 shares of the company’s stock after selling 1,024 shares during the quarter. GAMMA Investing LLC’s holdings in Avantor were worth $36,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also added to or reduced their stakes in the company. State Street Corp raised its holdings in Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after purchasing an additional 8,206,695 shares in the last quarter. 1832 Asset Management L.P. increased its holdings in shares of Avantor by 1,634.9% in the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock worth $180,839,000 after purchasing an additional 8,038,451 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Avantor by 653.0% during the third quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock valued at $159,740,000 after purchasing an additional 5,354,678 shares in the last quarter. FMR LLC increased its holdings in Avantor by 557.2% in the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company’s stock worth $120,950,000 after buying an additional 3,963,912 shares in the last quarter. Finally, Sound Shore Management Inc. CT bought a new stake in shares of Avantor in the second quarter worth approximately $76,412,000. 95.08% of the stock is owned by institutional investors.
Avantor Stock Down 1.4 %
Avantor stock opened at $21.71 on Wednesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The firm has a 50 day moving average price of $21.49 and a 200 day moving average price of $23.36. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The company has a market capitalization of $14.78 billion, a PE ratio of 47.20, a price-to-earnings-growth ratio of 2.75 and a beta of 1.28.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on Avantor
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
See Also
- Five stocks we like better than Avantor
- How to buy stock: A step-by-step guide for beginners
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Dividend Capture Strategy: What You Need to Know
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Want to Profit on the Downtrend? Downtrends, Explained.
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.